Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2020 | 04-2019 | 04-2018 | 04-2017 | 04-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,093 | 128 | -1,476 | -6,884 | -10,446 |
| Depreciation Amortization | 1,160 | 606 | 360 | 168 | 156 |
| Accounts receivable | -670 | -531 | -1,600 | -986 | -282 |
| Accounts payable and accrued liabilities | 333 | 653 | 301 | -43 | 482 |
| Other Working Capital | 2,610 | 18 | -1,561 | 1,146 | 1,209 |
| Other Operating Activity | 1,565 | 988 | 2,750 | 3,759 | 2,473 |
| Operating Cash Flow | $2,905 | $1,862 | $-1,226 | $-2,840 | $-6,408 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,220 | -834 | -1,226 | -766 | -322 |
| Investing Cash Flow | $-2,220 | $-834 | $-1,226 | $-766 | $-322 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -35 | -262 | -25 | -24 | -24 |
| Common Stock Issued | 4,455 | 1,465 | 38 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 4,340 | -18 |
| Financing Cash Flow | $4,420 | $1,203 | $13 | $4,316 | $-42 |
| Beginning Cash Position | 3,237 | 1,006 | 3,445 | 2,585 | 9,357 |
| End Cash Position | 8,342 | 3,237 | 1,006 | 3,295 | 2,585 |
| Net Cash Flow | $5,105 | $2,231 | $-2,439 | $710 | $-6,772 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,905 | 1,862 | -1,226 | -2,840 | -6,408 |
| Capital Expenditure | -2,220 | -834 | -1,229 | -766 | -322 |
| Free Cash Flow | 685 | 1,028 | -2,455 | -3,606 | -6,730 |